Genesis Healthcare (NYSE:GEN) will be issuing its quarterly earnings data after the market closes on Monday, March 19th. Analysts expect the company to announce earnings of ($0.27) per share for the quarter.

Genesis Healthcare (NYSE:GEN) opened at $1.62 on Monday. Genesis Healthcare has a 52 week low of $0.60 and a 52 week high of $2.85. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of -0.22.

How to Become a New Pot Stock Millionaire

An institutional investor recently raised its position in Genesis Healthcare stock. State Street Corp grew its position in Genesis Healthcare Inc (NYSE:GEN) by 3.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 778,728 shares of the company’s stock after purchasing an additional 26,825 shares during the period. State Street Corp owned about 0.95% of Genesis Healthcare worth $1,355,000 at the end of the most recent reporting period. 18.93% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Genesis Healthcare (GEN) Set to Announce Quarterly Earnings on Monday” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Earnings History for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with's FREE daily email newsletter.